|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
Rosiglitazone (BRL 49653) Enhances Insulin Secretory Response via Phosphatidylinositol 3-Kinase Pathway
1 Department of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan
2 Department of Internal Medicine, National Taiwan University Medical College, Taipei, Taiwan
3 Graduate Institute of Clinical Medicine, National Taiwan University Medical College, Taipei, Taiwan
4 Department of Biomedical Sciences, Iowa State University, Ames, Iowa
To elucidate the direct effect of rosiglitazone (RSG), a new thiazolidinedione antihyperglycemic agent, on pancreatic insulin secretion, an in situ investigation by rat pancreatic perfusion was performed. At a basal glucose concentration of 6 mmol/l, RSG (0.045–4.5 µmol/l) stimulated insulin release in a dose-dependent manner. In addition, 4.5 µmol/l RSG potentiated the glucose (10 mmol/l)-induced insulin secretion. Both the first and second phases of glucose-induced insulin secretion were significantly enhanced by RSG, by 80.7 and 52.4%, respectively. The effects of RSG on insulin secretion were inhibited by a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002. In contrast, the glucose-stimulated insulin secretion was not affected by LY294002. The potentiation effect of RSG on glucose-stimulated insulin secretion, in both the first and second phases, was significantly blocked by LY294002. These results suggest that RSG has a direct potentiation effect on insulin secretion in the presence of 10 mmol/l glucose, mediated through PI3K activity. The inability of LY294002 to inhibit glucose-induced insulin secretion suggests that different pathways are responsible for glucose and RSG signaling.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Moibi, D. Gupta, T. L. Jetton, M. Peshavaria, R. Desai, and J. L. Leahy Peroxisome Proliferator-Activated Receptor-{gamma} Regulates Expression of PDX-1 and NKX6.1 in INS-1 Cells Diabetes, January 1, 2007; 56(1): 88 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Schutt, J Zhou, M Meier, and H H Klein Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells J. Endocrinol., December 1, 2004; 183(3): 445 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Henquin Pathways in Beta-Cell Stimulus-Secretion Coupling as Targets for Therapeutic Insulin Secretagogues Diabetes, December 1, 2004; 53(suppl_3): S48 - S58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y-H Suh, S-Y Kim, H-Y Lee, B C Jang, J H Bae, J-N Sohn, J-H Bae, S-I Suh, J-W Park, K-U Lee, et al. Overexpression of short heterodimer partner recovers impaired glucose-stimulated insulin secretion of pancreatic {beta}-cells overexpressing UCP2 J. Endocrinol., October 1, 2004; 183(1): 133 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zeender, K. Maedler, D. Bosco, T. Berney, M. Y. Donath, and P. A. Halban Pioglitazone and Sodium Salicylate Protect Human {beta}-Cells against Apoptosis and Impaired Function Induced by Glucose and Interleukin-1{beta} J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5059 - 5066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Broca, V. Breil, C. Cruciani-Guglielmacci, M. Manteghetti, C. Rouault, M. Derouet, S. Rizkalla, B. Pau, P. Petit, G. Ribes, et al. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E463 - E471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lupi, S. Del Guerra, L. Marselli, M. Bugliani, U. Boggi, F. Mosca, P. Marchetti, and S. Del Prato Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPAR{gamma}2 in the modulation of insulin secretion Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E560 - E567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Rosen, R. N. Kulkarni, P. Sarraf, U. Ozcan, T. Okada, C.-H. Hsu, D. Eisenman, M. A. Magnuson, F. J. Gonzalez, C. R. Kahn, et al. Targeted Elimination of Peroxisome Proliferator-Activated Receptor {gamma} in {beta} Cells Leads to Abnormalities in Islet Mass without Compromising Glucose Homeostasis Mol. Cell. Biol., October 15, 2003; 23(20): 7222 - 7229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Srivastava and H. J. Goren Insulin Constitutively Secreted by {beta}-Cells Is Necessary for Glucose-Stimulated Insulin Secretion Diabetes, August 1, 2003; 52(8): 2049 - 2056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gum, L. L. Gaede, M. A. Heindel, J. F. Waring, J. M. Trevillyan, B. A. Zinker, M. E. Stark, D. Wilcox, M. R. Jirousek, C. M. Rondinone, et al. Antisense Protein Tyrosine Phosphatase 1B Reverses Activation of p38 Mitogen-Activated Protein Kinase in Liver of ob/ob Mice Mol. Endocrinol., June 1, 2003; 17(6): 1131 - 1143. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |